Arvinas, Inc. (ARVN)
7.65
-0.18
(-2.30%)
USD |
NASDAQ |
Sep 24, 09:56
Arvinas Cash from Operations (TTM) : -207.00M for June 30, 2026
Cash from Operations (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -207.00M |
| March 31, 2026 | -254.10M |
| December 31, 2025 | -273.80M |
| September 30, 2025 | -327.50M |
| June 30, 2025 | -396.40M |
| March 31, 2025 | -250.70M |
| December 31, 2024 | -259.30M |
| September 30, 2024 | -258.30M |
| June 30, 2024 | -215.10M |
| March 31, 2024 | -354.10M |
| December 31, 2023 | -347.80M |
| September 30, 2023 | -335.90M |
| June 30, 2023 | -317.70M |
| March 31, 2023 | -307.60M |
| December 31, 2022 | -273.50M |
| September 30, 2022 | -238.05M |
| June 30, 2022 | 510.07M |
| March 31, 2022 | 541.27M |
| Date | Value |
|---|---|
| December 31, 2021 | 559.40M |
| September 30, 2021 | 566.13M |
| June 30, 2021 | -137.78M |
| March 31, 2021 | -111.78M |
| December 31, 2020 | -89.76M |
| September 30, 2020 | -76.91M |
| June 30, 2020 | -52.68M |
| March 31, 2020 | -44.84M |
| December 31, 2019 | -40.63M |
| September 30, 2019 | -36.70M |
| June 30, 2019 | -49.54M |
| March 31, 2019 | -48.15M |
| December 31, 2018 | -16.12M |
| September 30, 2018 | 24.29M |
| June 30, 2018 | 27.84M |
| March 31, 2018 | 31.49M |
| December 31, 2017 | 5.113M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Cocrystal Pharma, Inc. | -8.263M |
| CNBX Pharmaceuticals, Inc. | -0.1542M |
| GB Sciences, Inc. | -- |
| Fulcrum Therapeutics, Inc. | -65.78M |
| Definium Therapeutics, Inc. | -166.74M |